/
/
/

Syncom Formulations (India) Balance Sheet

Consolidated
Standalone
₹
%

Share Price Live Stats

Open (₹)19.07
Volume (₹)98.87 L
High (₹)20.57
Upper Circuit22.88
Low (₹)18.95
Lower Circuit15.26
Prev Close19.07
52W High (₹)27.49
Price20.30
52W Low (₹)10.21

Share Market Cap & Key Ratios Overview

M.Cap (₹)1794.46 Cr
Div. Yield (%)0.52
PE Ratio20.98
Debt to Equity0.00
Price to Book2.33
Book Value4.41
EPS (TTM)0.91
Face Value1.00
ROE (%)20.19

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
LAURUSLABSNSE
ZYDUSLIFENSE
DRREDDYNSE
CIPLANSE
MANKINDNSE
AUROPHARMANSE
LUPINNSE
SYNCOMFNSE
LTP
1W Low
1W High
Market cap (₹)
1790.6+12.9 (0.73%)
1722
1810.40
4,25,150Cr
10012.5+232.5 (2.38%)
9863
10067
2,66,265Cr
4678.7+65.3 (1.42%)
4553
4698.50
1,76,301Cr
2314.7-90.8 (-3.77%)
2252.40
2441.90
1,25,352Cr
1200-45.5 (-3.65%)
1192
1266.60
1,23,591Cr
1366.2+14.2 (1.05%)
1336.70
1376.70
1,14,351Cr
1391.2+12.3 (0.89%)
1364.60
1400.80
1,12,474Cr
2481.2-11.6 (-0.47%)
2457.90
2512.30
1,02,315Cr
1701.1+19.7 (1.17%)
1656.20
1713.80
97,757Cr
2026.8+15.8 (0.79%)
1988.90
2062.10
92,007Cr
20.3+1.06 (5.51%)
18.88
20.57
1,794Cr

Key Highlights of Syncom Formulations (India) Ltd Balance Sheet

Syncom Formulations (India) Ltd balance sheet discloses shareholders' funds of ₹94Cr as of 2025-03-31. The company’s equity share capital is at a value of ₹94Cr, and the reserves and surplus of the company is ₹245.9Cr.

The company has its non-current liabilities with total liabilities of ₹412.1Cr as of 2025-03-31.

The current liabilities are ₹60.38Cr as of 2025-03-31. At the same time, current assets are ₹269.88Cr as of 2025-03-31.

Key assets on the balance sheet are non-current investments of ₹3.65Cr and tangible assets of ₹77.57Cr, provided in the Syncom Formulations (India) Ltd financial statements.